The final, formatted version of the article will be published soon. Background: Immune checkpoint inhibitors (ICIs) have revolutionized advanced hepatocellular carcinoma (HCC) treatment, yet complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback